Yiling Pharmaceutical: Lianhua Qingwen Approved in Nigeria
As of now, Lianhua Qingwen has been granted market access in nearly 30 countries and regions. It has been approved COVID-19 indications in Kuwait; in July 2021, it has been adopted as a treatment in the COVID-19 patients' self-care protocol at home by the Cambodian Ministry of Health. As of now,Lianhua Qingwenhas been granted market access in nearly 30 countries and regions. It has been approved COVID-19 indications inKuwait ; inJuly 2021, it has been adopted as a treatment in the...
Comunicato Precedente
Comunicato Successivo
SHIJIAZHUANG, China,
(informazione.news - comunicati stampa - scienza e tecnologia)
As of now, Lianhua Qingwen has been granted market access in nearly 30 countries and regions. It has been approved COVID-19 indications in Kuwait; in July 2021, it has been adopted as a treatment in the COVID-19 patients' self-care protocol at home by the Cambodian Ministry of Health.
As the largest economic entity (GDP of USD 432.3 Billion in 2020) and most populous country (206 million people) in Africa, Nigeria is the headquarters of the Economic Community of West African States (ECOWAS) and becomes the 8th African country that has approved Lianhua Qingwen.
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
;




